(Q73218725)
Statements
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20( ) B-cell non-Hodgkin's lymphoma (English)
T E Witzig
C A White
G A Wiseman
L I Gordon
C Emmanouilides
A Raubitschek
N Janakiraman
J Gutheil
R J Schilder
S Spies
D H Silverman
E Parker
A J Grillo-López
1 December 1999